Viewpoints » Everything You Need to Know about Trichomonas Featuring Dr. Ina Park

06/10/2023Viewpoint

Everything You Need to Know about Trichomonas Featuring Dr. Ina Park

CME on-demand webinar presented by ASHA | A comprehensive guide for the detection and management of the often neglected sexually transmitted infection, Trichomoniasis.

Everything You Need to Know about Trichomonas Featuring Dr. Ina Park

CME on-demand webinar presented by ASHA

American Sexual Health Association (ASHA)

 

Jointly provided by Partners for Advancing Clinical Education (PACE) and the American Sexual Health Association. This activity is supported by an independent education grant from Visby Medical.

Release date: April 11, 2023
Expiration date: April 11, 2024
Estimated time to complete activity: 1.0 hour

Computer system hardware/software requirements: Access to an Internet browser and a high-speed Internet connection.
For additional information about the accreditation of this activity, please visit https://partnersed.com

1.0 CE/AMA Credits valid through April 11, 2024

Dr. Ina Park
Associate Professor Family Community Medicine
University of California San Francisco School of Medicine

Description

A comprehensive guide for the detection and management of the often neglected sexually transmitted infection, Trichomoniasis.

Learning Objectives

  • Choose appropriate diagnostic testing strategies for trichomonas with high sensitivity and specificity
  • Prescribe treatment for patients with trichomonas and their partners according to the updated 2021 CDC Treatment Guideline
  • Answer patient questions with concise, comprehensible counseling messages
  • Assess risk factors for trichomonas and determine appropriate patients for screening according to the 2021 CDC guidelines

Method of Participation and Request for Credit

Participation in this self-study activity should be completed in approximately 1.0 hour. To successfully complete this activity and receive CE credit, learners must follow these steps during the period from April 11, 2023 through April 11, 2024:

  1. Review the objectives and disclosures
  2. Study the educational content
  3. Visit this link and create an account
  4. Successfully complete activity post-test
  5. Complete the activity evaluation

You must receive a test score of at least 70% and respond to all evaluation questions to receive a certificate.

 

Read more articles & insights

04/05/2024Viewpoint

The Case for PCR at the Point of Care: Reshaping STI Testing in Urgent Care Clinics

In light of the rising rates of sexually transmitted infections (STIs), urgent care clinics have found themselves at a crucial crossroads. PCR (Polymerase Chain Reaction) testing at the point of care emerges as a potential game-changer.

Read More
The Case for PCR at the Point of Care: Reshaping STI Testing in Urgent Care Clinics

03/14/2024Viewpoint

Understanding the Financial Impact of PCR Point of Care Testing for STIs

The adoption of point-of-care polymerase chain reaction (PCR) testing represents a significant leap forward in diagnostic capabilities. With its promise of speed, accuracy, and efficiency, PCR testing technology is setting a new standard in patient care.

Read More
Understanding the Financial Impact of PCR Point of Care Testing for STIs

03/07/2024Viewpoint

5 Frequently Asked Questions on Implementing PCR into Urgent Care

The adoption of point-of-care polymerase chain reaction (PCR) testing represents a significant leap forward in diagnostic capabilities. With its promise of speed, accuracy, and efficiency, PCR testing technology is setting a new standard in patient care.

Read More
5 Frequently Asked Questions on Implementing PCR into Urgent Care

02/21/2024Press Release

CARB-X awards funding to Visby Medical for gonorrhea, antibiotic susceptibility test

The Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) announced today that it will award biotechnology company Visby Medical of San Jose, California, up to $1.8 million to develop a portable polymerase chain reaction (PCR) test that can detect gonorrhea and assess its susceptibility to ciprofloxacin.

Read More
CARB-X awards funding to Visby Medical for gonorrhea, antibiotic susceptibility test